早期输血模式改善了分子国际预后评分系统 (IPSS-M) 在骨髓质疏松综合征的预测
Maria Creignou1,2, Elsa Bernard3,4, Alessandro Gasparini5
1Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Journal of internal medicine
|April 24, 2024
概括
骨髓发育综合征 (MDS) 中的输血依赖性提供了动态的风险信息. 早期输血状态显著预测了结果,改善了超出分子国际预后评分系统 (IPSS-M) 的预后模型.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 分子国际预后评分系统 (IPSS-M) 是目前用于预测骨髓发育综合征 (MDS) 结果的标准.
- 在MDS患者的早期随访中,动态输血参数的预后价值尚未完全阐明.
研究的目的:
- 评估MDS患者早期随访期间动态输血参数对增值预后的影响.
- 评估输血状态是否会改善结局预测,当与IPSS-M结合使用时.
主要方法:
- 来自IPSS-M队列的677名成年瑞典MDS患者的队列进行了他们的输血数据分析.
- 时间依赖的红细胞输血依赖性 (E-TD) 被纳入了IPSS-M框架.
- 使用多态马尔科夫模型分析整体存活率和白血病转变,评估输血模式的早期变化.
主要成果:
- 诊断时和第一年内输血状态强烈预测了低风险 (LR) 和高风险 (HR) MDS的结果.
- 与单独使用IPSS-M相比,八个月的里程碑 E-TD 独立预测了较短的生存期 (p < 0.001).
- 与单独IPSS-M相比,IPSS-M和8个月E-TD的组合模型显示出优异的预测性能,在一个独立的队列中得到验证.
结论:
- 输血要求是一个强大的临床参数,在MDS中动态反映治疗效果和患者状态.
- 早期输血模式独立于IPSS-M提供预后信息,特别是指导LR MDS患者的治疗干预.
相关概念视频
01:22iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
01:22Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K